Dziubla:Publications - Revision history

Thomas Dziubla at 15:51, 9 October 2011

Thomas Dziubla — Sun, 09 Oct 2011 15:51:56 GMT

Thomas Dziubla at 20:38, 17 February 2011

Thomas Dziubla — Thu, 17 Feb 2011 20:38:17 GMT

←Older revision		Revision as of 20:38, 17 February 2011
Line 16:		Line 16:
	E Simone*, T. Dziubla, E Arguiri, V Vardon, V Shuvaev, M Christofidou-Solomidou and V Muzykantov. “[http://www.ncbi.nlm.nih.gov/pubmed/18956141 Loading PEG-catalase into filamentous and spherical polymer nanocarriers]” Pharmaceutical Research 26:250-60 (2009)		E Simone*, T. Dziubla, E Arguiri, V Vardon, V Shuvaev, M Christofidou-Solomidou and V Muzykantov. “[http://www.ncbi.nlm.nih.gov/pubmed/18956141 Loading PEG-catalase into filamentous and spherical polymer nanocarriers]” Pharmaceutical Research 26:250-60 (2009)

-	E. Simone, T.D. Dziubla, and V. R Muzykantov., ~~“Polymeric~~ Carriers: Role of Geometry in Drug Delivery.” Expert Opinion on Drug Delivery 5:1283-1300 (2008)	+	E. Simone, T.D. Dziubla, and V. R Muzykantov., “[http://www.ncbi.nlm.nih.gov/pubmed/19040392 Polymeric Carriers: Role of Geometry in Drug Delivery.]” Expert Opinion on Drug Delivery 5:1283-1300 (2008)

-	M. Howard, M Jay, T. Dziubla, X. Lu*, ~~“PEGylation~~ of Nanocarrier Drug Delivery Systems: State of the Art.” J Biomed Nanotech 4:133-148 (2008)	+	M. Howard, M Jay, T. Dziubla, X. Lu*, “[http://www.ingentaconnect.com/content/asp/jbn/2008/00000004/00000002/art00002 PEGylation of Nanocarrier Drug Delivery Systems: State of the Art.]” J Biomed Nanotech 4:133-148 (2008)

-	C. Garnacho, R. Dhami, E. Simone, T. Dziubla, J. Leferovich, E. H. Schuchman, V. Muzykantov, and S. Muro*. ~~“Delivery~~ of acid sphingomyelinase in normal and Niemann-Pick disease mice using ICAM-1-targeted polymer ~~nanoparticles”~~ JPET 325:400-408 (2008)	+	C. Garnacho, R. Dhami, E. Simone, T. Dziubla, J. Leferovich, E. H. Schuchman, V. Muzykantov, and S. Muro*. “[http://www.ncbi.nlm.nih.gov/pubmed/18287213 Delivery of acid sphingomyelinase in normal and Niemann-Pick disease mice using ICAM-1-targeted polymer nanoparticles]” JPET 325:400-408 (2008)

-	T.D. Dziubla*, V.V. Shuvaev, N.K. Hong, B. Hawkins, M. Muniswamy, H. Takano, E. Simone, M.T. Nakada, A. Fisher, S.M. Albelda, and V.R. Muzykantov, ~~“Endothelial~~ Targeting of Semi-permeable Polymer Nanocarriers for Enzyme Therapies.” Biomaterials 2:215-27 (2008)	+	T.D. Dziubla*, V.V. Shuvaev, N.K. Hong, B. Hawkins, M. Muniswamy, H. Takano, E. Simone, M.T. Nakada, A. Fisher, S.M. Albelda, and V.R. Muzykantov, “[http://www.ncbi.nlm.nih.gov/pubmed/17950837 Endothelial Targeting of Semi-permeable Polymer Nanocarriers for Enzyme Therapies.]” Biomaterials 2:215-27 (2008)

-	E. Simone*, T. Dziubla, F. Colon, D. Discher and V.R. Muzykantov. ~~“Amphiphilicity~~ of PEG-PLA diblock copolymer controls the formulation and morphology of nanocarriers protecting loaded therapeutic enzyme from ~~proteolysis”~~ Biomacromolecules 8:3914-21 (2007)	+	E. Simone*, T. Dziubla, F. Colon, D. Discher and V.R. Muzykantov. “[http://www.ncbi.nlm.nih.gov/pubmed/18038999 Amphiphilicity of PEG-PLA diblock copolymer controls the formulation and morphology of nanocarriers protecting loaded therapeutic enzyme from proteolysis]” Biomacromolecules 8:3914-21 (2007)

-	S. Muro*, T.D. Dziubla, W. Qui, J. Leferovich, X. Cui, E. Berk and V.R. Muzykantov ~~“Endothelial~~ targeting of high-affinity multivalent polymer nanocarriers directed to ICAM-1.” JPET 317(3):1161-9 (2006)	+	S. Muro*, T.D. Dziubla, W. Qui, J. Leferovich, X. Cui, E. Berk and V.R. Muzykantov “[http://www.ncbi.nlm.nih.gov/pubmed/16505161 Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to ICAM-1.]” JPET 317(3):1161-9 (2006)

-	Ding BS, Dziubla T, Shuvaev VV, Muro S, Muzykantov VR. ~~“Advanced~~ drug delivery systems that target the vascular endothelium.” Mol Interv. 2:98-112 (2006)	+	Ding BS, Dziubla T, Shuvaev VV, Muro S, Muzykantov VR. “[http://www.ncbi.nlm.nih.gov/pubmed/16565472 Advanced drug delivery systems that target the vascular endothelium.]” Mol Interv. 2:98-112 (2006)

-	T.D. Dziubla*, A. Karim and V. Muzykantov, ~~“Polymer~~ nanocarriers (PNC) protect loaded catalase cargo from proteolysis.” Journal of Controlled Release 102(2), 427-439, (2005)	+	T.D. Dziubla*, A. Karim and V. Muzykantov, “[http://www.ncbi.nlm.nih.gov/pubmed/15653162 Polymer nanocarriers (PNC) protect loaded catalase cargo from proteolysis.]” Journal of Controlled Release 102(2), 427-439, (2005)

-	T.D. Dziubla and A.M. Lowman*, ~~“Vascularization~~ of PEG-grafted macroporous hydrogel sponges: a 3-dimensional in vitro angiogenesis model utilizing human microvascular endothelial cells.” Journal of Biomedical Materials Research. 68A (4): 603-614, (2004)	+	T.D. Dziubla and A.M. Lowman*, “[http://www.ncbi.nlm.nih.gov/pubmed/14986316 Vascularization of PEG-grafted macroporous hydrogel sponges: a 3-dimensional in vitro angiogenesis model utilizing human microvascular endothelial cells.]” Journal of Biomedical Materials Research. 68A (4): 603-614, (2004)

-	T.D. Dziubla, M.C. Torjman, J.I. Joseph, M. Murphy-Tatum and A.M. Lowman*, "Evaluation of porous networks of poly(2-hydroxyethyl methacrylate) as interfacial drug delivery devices." Biomaterials 22, 2893-2899, (2001)	+	T.D. Dziubla, M.C. Torjman, J.I. Joseph, M. Murphy-Tatum and A.M. Lowman*, "[http://www.ncbi.nlm.nih.gov/pubmed/11561895 Evaluation of porous networks of poly(2-hydroxyethyl methacrylate) as interfacial drug delivery devices.]" Biomaterials 22, 2893-2899, (2001)

Thomas Dziubla at 20:17, 17 February 2011

Thomas Dziubla — Thu, 17 Feb 2011 20:17:36 GMT

←Older revision		Revision as of 20:17, 17 February 2011
Line 1:		Line 1:
	{{Template:Dziubla}}		{{Template:Dziubla}}
		+	M. Howard, X. Lu, J. Rinehart, M. Jay and T. Dziubla* “[http://www.ncbi.nlm.nih.gov/pubmed/21190351 Physicochemical Characterization of Nanotemplate Engineered Solid Lipid Nanoparticles]” Langmuir (2010)
		+
		+	J. Kim, M. Howard, T. Dziubla, J. Rinehart, M. Jay and X. Lu * “[http://www.ncbi.nlm.nih.gov/pubmed/21158414 Uniformity of Drug Payload and its Effect on Stability of Solid Lipid Nanoparticles Containing an Ester Prodrug]” ACS Nano (accepted)
		+
		+	J. Medley, Heisterberg J, and T Dziubla* “[http://www.ncbi.nlm.nih.gov/pubmed/20573320 Synthesis and Characterization of CREKA-Targeted Polymers for the Disruption of Fibrin Gel Matrix Propagation.]” J Biomater Sci:Poly Ed (E Pub 2010)
		+
		+	P. Wattamwar, Y. Mo, R. Wan, R. Palli, Q. Zhang and T. Dziubla*, “[http://onlinelibrary.wiley.com/doi/10.1002/adfm.200900839/abstract Antioxidant Activity of Degradable Polymer Poly(trolox ester) to Suppress Oxidative Stress Injury in the Cells.]” Advanced Functional Materials 20:147-154 (2010)
		+
		+	Y Ma, Y Xiong*, J Zhai, H Zhu, and T Dziubla, “[http://www.ncbi.nlm.nih.gov/pubmed/20352082 Fractionation and Evaluation of Radical Scavenging Peptides from in vitro Digests of Buckwheat Protein.]” Food Chemistry 118:582-588 (2010)
		+
		+	J. Medley, E. Beane, E. Kaplan and T Dziubla* “[http://www.ncbi.nlm.nih.gov/pubmed/19607939 Block copolymers for the rational design of self-forming postsurgical adhesion barriers.]” Acta Biomaterialia 6:72-82 (2010)
		+
		+	E Simone*, T Dziubla, D Discher, and V Muzykantov. “[http://www.ncbi.nlm.nih.gov/pubmed/19385657 Filamentous polymer nanocarriers of tunable stiffness that encapsulate the therapeutic enzyme catalase.]” Biomacromolecules 10:1324-30 (2009)
		+
		+	E Simone*, T. Dziubla, E Arguiri, V Vardon, V Shuvaev, M Christofidou-Solomidou and V Muzykantov. “[http://www.ncbi.nlm.nih.gov/pubmed/18956141 Loading PEG-catalase into filamentous and spherical polymer nanocarriers]” Pharmaceutical Research 26:250-60 (2009)
		+
		+	E. Simone, T.D. Dziubla, and V. R Muzykantov., “Polymeric Carriers: Role of Geometry in Drug Delivery.” Expert Opinion on Drug Delivery 5:1283-1300 (2008)
		+
		+	M. Howard, M Jay, T. Dziubla, X. Lu*, “PEGylation of Nanocarrier Drug Delivery Systems: State of the Art.” J Biomed Nanotech 4:133-148 (2008)
		+
		+	C. Garnacho, R. Dhami, E. Simone, T. Dziubla, J. Leferovich, E. H. Schuchman, V. Muzykantov, and S. Muro*. “Delivery of acid sphingomyelinase in normal and Niemann-Pick disease mice using ICAM-1-targeted polymer nanoparticles” JPET 325:400-408 (2008)
		+
		+	T.D. Dziubla*, V.V. Shuvaev, N.K. Hong, B. Hawkins, M. Muniswamy, H. Takano, E. Simone, M.T. Nakada, A. Fisher, S.M. Albelda, and V.R. Muzykantov, “Endothelial Targeting of Semi-permeable Polymer Nanocarriers for Enzyme Therapies.” Biomaterials 2:215-27 (2008)
		+
		+	E. Simone*, T. Dziubla, F. Colon, D. Discher and V.R. Muzykantov. “Amphiphilicity of PEG-PLA diblock copolymer controls the formulation and morphology of nanocarriers protecting loaded therapeutic enzyme from proteolysis” Biomacromolecules 8:3914-21 (2007)
		+
		+	S. Muro*, T.D. Dziubla, W. Qui, J. Leferovich, X. Cui, E. Berk and V.R. Muzykantov “Endothelial targeting of high-affinity multivalent polymer nanocarriers directed to ICAM-1.” JPET 317(3):1161-9 (2006)
		+
		+	Ding BS, Dziubla T, Shuvaev VV, Muro S, Muzykantov VR. “Advanced drug delivery systems that target the vascular endothelium.” Mol Interv. 2:98-112 (2006)
		+
		+	T.D. Dziubla*, A. Karim and V. Muzykantov, “Polymer nanocarriers (PNC) protect loaded catalase cargo from proteolysis.” Journal of Controlled Release 102(2), 427-439, (2005)
		+
		+	T.D. Dziubla and A.M. Lowman*, “Vascularization of PEG-grafted macroporous hydrogel sponges: a 3-dimensional in vitro angiogenesis model utilizing human microvascular endothelial cells.” Journal of Biomedical Materials Research. 68A (4): 603-614, (2004)
		+
		+	T.D. Dziubla, M.C. Torjman, J.I. Joseph, M. Murphy-Tatum and A.M. Lowman*, "Evaluation of porous networks of poly(2-hydroxyethyl methacrylate) as interfacial drug delivery devices." Biomaterials 22, 2893-2899, (2001)

Thomas Dziubla: New page: {{Template:Dziubla}}

Thomas Dziubla — Thu, 31 Jan 2008 03:45:31 GMT

New page: {{Template:Dziubla}}

New page